E Fund Management Co., Ltd. Prometheus Biosciences, Inc. Transaction History

E Fund Management Co., Ltd.

  • $1.93 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
SELL
$103.46 - $126.29 $47,488 - $57,967
-459 Reduced 11.97%
3,377 $362,000
Q4 2022

Feb 14, 2023
SELL
$36.06 - $117.21 $97,217 - $315,998
-2,696 Reduced 41.27%
3,836 $422,000
Q3 2022

Nov 14, 2022
BUY
$28.17 - $59.01 $184,006 - $385,453
6,532 New
6,532 $385,000

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email